PLX Operating Cash Flow (Statement)

Protalix Biotherapeutics Inc · Operating Cash Flow (Statement)

PLX logo

PLX Operating Cash Flow (Statement)

Latest reported$9.92M
PLX TTM Cash from Operations (-$610.00K → $9.92M)
High-resolution chart · PNG

PLX operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Protalix Biotherapeutics Inc Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (Statement) (USD)
9,923,000
15,090,000
-11,993,000
-10,032,000
-2,195,000
-572,000
8,674,000
8,278,000
-2,715,000
5,868,000
-1,318,000
-7,524,000
-9,840,000
-22,169,000
-25,000,000
-27,476,000
-20,152,000
-6,280,000
-10,285,000
-12,748,000
-14,472,000
-28,823,000
-26,106,000
-22,243,000
-21,864,000
-19,199,000
-19,358,000
-19,675,000
-2,811,000
-5,605,000
-7,742,000
13,852,000
-10,326,000
-10,981,000
-9,994,000
-34,922,000
-27,826,000
-30,899,000
-32,098,000
-28,617,000
-33,834,000
-27,488,000
-24,284,000
-25,301,000
-26,189,000
-27,362,000
-29,281,000
-29,149,000
-27,817,000
-29,407,000
-30,653,000
-24,090,000
-23,903,000
-2,670,000
635,000
-7,798,000
-7,916,000
-25,863,000
-23,570,000
-24,989,000
-26,522,000
-33,507,000
-38,464,000
28,685,000
32,954,000
41,489,000
44,452,000
-16,905,000
-17,823,000
-18,190,000
-16,015,000
-17,636,000
-12,980,000
-11,437,000
-10,449,000
-11,520,464
-9,946,633
-7,856,486
-5,091,000
-162,088
-84,283
-95,467
-72,475
-85,275
-106,989
-132,426
-168,125
-176,988
-154,438
-153,751
-136,682
-138,722
-140,921
-133,482
-146,586
-1,445,805
-1,456,656
-765,999
-789,428
671,665
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.